Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 45-65 women with amenorrhea for over 24 months.~* Clinical vaginal atrophy diagnosis.~Exclusion Criteria:~* BMI \> 35.~* Previous use of oral estrogen therapy in the last 6 months.~* History or current diagnosis of cancer.~* Altered cervical smear in the last 12 months.~* Renal or hepatic insufficiency.~* Drug-induced menopause.~* Previous use of steroids.~* Previous vaginal radiotherapy therapy.~* Vulvovaginitis.

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- CO2 laser & Estrogen (Type: EXPERIMENTAL): Effective fractional CO2 laser therapy and effective estrogen vaginal cream
- CO2 laser & Placebo of Estrogen (Type: ACTIVE_COMPARATOR): Effective fractional CO2 laser therapy and placebo of estrogen vaginal cream.
- Placebo of CO2 laser & Estrogen (Type: SHAM_COMPARATOR): Placebo fractional CO2 laser therapy and effective estrogen vaginal cream.

Based on this trial design, predict the completion outcome and termination type (if applicable).